| scholarly article | Q13442814 |
| review article | Q7318358 |
| P2093 | author name string | Jessica M Jones | |
| Trine N Jørgensen | |||
| P2860 | cites work | Myeloid-derived suppressor cells as regulators of the immune system | Q28131637 |
| Bone marrow stromal cells mediate androgenic suppression of B lymphocyte development | Q28365790 | ||
| CD19(+)CD24(hi)CD38(hi) B cells exhibit regulatory capacity in healthy individuals but are functionally impaired in systemic Lupus Erythematosus patients | Q34093165 | ||
| Characterization of a rare IL-10-competent B-cell subset in humans that parallels mouse regulatory B10 cells. | Q34144779 | ||
| Dehydroepiandrosterone treatment of women with mild-to-moderate systemic lupus erythematosus: a multicenter randomized, double-blind, placebo-controlled trial | Q34158711 | ||
| Plasmacytoid dendritic cell interferon-α production to R-848 stimulation is decreased in male infants. | Q34329421 | ||
| From Monocytes to M1/M2 Macrophages: Phenotypical vs. Functional Differentiation | Q34359869 | ||
| An open study of dehydroepiandrosterone in systemic lupus erythematosus | Q34725009 | ||
| Gonadectomy of male BALB/c mice increases Tim-3(+) alternatively activated M2 macrophages, Tim-3(+) T cells, Th2 cells and Treg in the heart during acute coxsackievirus-induced myocarditis | Q35143201 | ||
| Animal Models of Interferon Signature Positive Lupus | Q35686914 | ||
| Interleukin-6 exacerbates glomerulonephritis in (NZB x NZW)F1 mice | Q35833886 | ||
| Androgen receptor modulates Foxp3 expression in CD4+CD25+Foxp3+ regulatory T-cells | Q36063781 | ||
| A Regulatory Feedback between Plasmacytoid Dendritic Cells and Regulatory B Cells Is Aberrant in Systemic Lupus Erythematosus | Q36718239 | ||
| Activated renal macrophages are markers of disease onset and disease remission in lupus nephritis | Q36985612 | ||
| IFN-γ differentially regulates subsets of Gr-1(+)CD11b(+) myeloid cells in chronic inflammation. | Q39624968 | ||
| TLR7 ligands induce higher IFN-alpha production in females. | Q40247926 | ||
| Low plasma androgens in women with systemic lupus erythematosus | Q41331741 | ||
| Patients with systemic lupus erythematosus and secondary antiphospholipid syndrome have decreased numbers of circulating CD4⁺CD25⁺Foxp3⁺ Treg and CD3⁻CD19⁺ B cells | Q41920666 | ||
| Forkhead box p3+ regulatory T cell underlies male resistance to experimental type 2 autoimmune hepatitis | Q43128400 | ||
| Effects of dehydroepiandrosterone on fatigue and well-being in women with quiescent systemic lupus erythematosus: a randomised controlled trial | Q43255461 | ||
| Quantitative and qualitative deficiencies of regulatory T cells in patients with systemic lupus erythematosus (SLE). | Q44098845 | ||
| Androgenic status of males with systemic lupus erythematosus | Q44156151 | ||
| Evidence for the presence of androgen receptors in the synovial tissue of rheumatoid arthritis patients and healthy controls | Q44815684 | ||
| Effects of prasterone on disease activity and symptoms in women with active systemic lupus erythematosus | Q45081882 | ||
| Development of systemic lupus erythematosus in a male-to-female transsexual: the role of sex hormones revisited | Q45721965 | ||
| Effect of estrogen and progesterone on macrophage activation during wound healing | Q46157697 | ||
| Myeloid-derived suppressor cells contribute to systemic lupus erythaematosus by regulating differentiation of Th17 cells and Tregs | Q46541732 | ||
| Elimination of Granulocytic Myeloid-Derived Suppressor Cells in Lupus-Prone Mice Linked to Reactive Oxygen Species-Dependent Extracellular Trap Formation | Q46662797 | ||
| Testosterone patches in the management of patients with mild/moderate systemic lupus erythematosus | Q46780001 | ||
| Effects of dehydroepiandrosterone supplement on health-related quality of life in glucocorticoid treated female patients with systemic lupus erythematosus | Q46864446 | ||
| Dihydrotestosterone levels at birth associate positively with higher proportions of circulating immature/naïve CD5+ B cells in boys | Q46974888 | ||
| Significant symptomatic improvement of subacute cutaneous lupus after testosterone therapy in a female-to-male transgender subject | Q47616038 | ||
| IL-6 receptor blockage inhibits the onset of autoimmune kidney disease in NZB/W F1 mice | Q47901598 | ||
| Neutrophils Slow Disease Progression in Murine Lupus via Modulation of Autoreactive Germinal Centers | Q48325825 | ||
| Myeloid-Derived Suppressor Cells Induce the Expansion of Regulatory B Cells and Ameliorate Autoimmunity in the Sanroque Mouse Model of Systemic Lupus Erythematosus | Q48955929 | ||
| Gr-1(high) CD11b+ cells suppress B cell differentiation and lupus-like disease in lupus-prone male mice. | Q50919779 | ||
| Gr1+ cells suppress T-dependent antibody responses in (NZB x NZW)F1 male mice through inhibition of T follicular helper cells and germinal center formation. | Q51167398 | ||
| A double-blind, placebo-controlled, clinical trial of dehydroepiandrosterone in severe systemic lupus erythematosus. | Q53931682 | ||
| Treatment of systemic lupus erythematosus with dehydroepiandrosterone: 50 patients treated up to 12 months. | Q53958684 | ||
| Factors Influencing the Differentiation of Human Monocytic Myeloid-Derived Suppressor Cells Into Inflammatory Macrophages. | Q55040962 | ||
| Testosterone is an endogenous regulator of BAFF and splenic B cell number. | Q55171520 | ||
| Androgen-Induced Immunosuppression. | Q55357541 | ||
| Adoptive Regulatory T Cell Therapy in a Patient with Systemic Lupus Erythematosus | Q57052192 | ||
| Androgen and Androgen Receptor as Enhancers of M2 Macrophage Polarization in Allergic Lung Inflammation | Q57284683 | ||
| Sex Hormones Determine Immune Response | Q58700785 | ||
| Novel Treatments in Lupus | Q59798146 | ||
| Identification of alterations in macrophage activation associated with disease activity in systemic lupus erythematosus | Q60301328 | ||
| Phenotypic and Functional Diversities of Myeloid-Derived Suppressor Cells in Autoimmune Diseases | Q60935643 | ||
| Loss of the androgen receptor suppresses intrarenal calcium oxalate crystals deposition via altering macrophage recruitment/M2 polarization with change of the miR-185-5p/CSF-1 signals | Q64069377 | ||
| Regulating IRFs in IFN Driven Disease | Q64102243 | ||
| Suppressed androgen receptor expression promotes M2 macrophage reprogramming through the STAT3/SOCS3 pathway | Q64298437 | ||
| Research Progress on Regulatory B Cells in Systemic Lupus Erythematosus. | Q64996308 | ||
| Increased CD14+HLA-DR-/low Myeloid-Derived Suppressor Cells Correlate With Disease Severity in Systemic Lupus Erythematosus Patients in an iNOS-Dependent Manner. | Q64998120 | ||
| Plasma sex hormones and aromatase activity in tissues of patients with systemic lupus erythematosus | Q67482142 | ||
| Experience with 19-nortestosterone in the therapy of systemic lupus erythematosus: worsened disease after treatment with 19-nortestosterone in men and lack of improvement in women | Q68136500 | ||
| Sex hormones in male patients with systemic lupus erythematosus: a comparison with other disease groups | Q70510524 | ||
| Castration alters peripheral immune function in normal male mice | Q72238590 | ||
| Plasma androgens in women with disseminated lupus erythematosus | Q72780327 | ||
| Alterations in peripheral B cells and B cell progenitors following androgen ablation in mice | Q73702849 | ||
| Testosterone suppresses anti-DNA antibody production in peripheral blood mononuclear cells from patients with systemic lupus erythematosus | Q73766197 | ||
| Profile of sex hormones in male patients with systemic lupus erythematosus | Q73922586 | ||
| New onset systemic lupus erythematosus in a transgender man: possible role of feminizing sex hormones | Q79721086 | ||
| Dysfunctional CD4+,CD25+ regulatory T cells in untreated active systemic lupus erythematosus secondary to interferon-alpha-producing antigen-presenting cells | Q80800895 | ||
| Macrophage Polarization Modulates Development of Systemic Lupus Erythematosus | Q86363420 | ||
| Regulatory T cells in autoimmune disease | Q89171054 | ||
| BAFF inhibition attenuates fibrosis in scleroderma by modulating the regulatory and effector B cell balance | Q90225269 | ||
| Update on the epidemiology, risk factors, and disease outcomes of systemic lupus erythematosus | Q90346707 | ||
| B cell alterations during BAFF inhibition with belimumab in SLE | Q90795990 | ||
| PAM3 supports the generation of M2-like macrophages from lupus patient monocytes and improves disease outcome in murine lupus | Q91208596 | ||
| New-onset lupus nephritis after male-to-female sex reassignment surgery | Q91550342 | ||
| Biologics in the Treatment of Lupus Erythematosus: A Critical Literature Review | Q92513141 | ||
| Therapeutic effects of a novel BAFF blocker on arthritis | Q92972089 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P921 | main subject | anti-inflammatory agent | Q581996 |
| P304 | page(s) | 1271 | |
| P577 | publication date | 2020-06-23 | |
| P1433 | published in | Frontiers in Immunology | Q27723748 |
| P1476 | title | Androgen-Mediated Anti-inflammatory Cellular Processes as Therapeutic Targets in Lupus | |
| P478 | volume | 11 |
Search more.